1141 related articles for article (PubMed ID: 27158780)
1. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.
Campbell JD; Alexandrov A; Kim J; Wala J; Berger AH; Pedamallu CS; Shukla SA; Guo G; Brooks AN; Murray BA; Imielinski M; Hu X; Ling S; Akbani R; Rosenberg M; Cibulskis C; Ramachandran A; Collisson EA; Kwiatkowski DJ; Lawrence MS; Weinstein JN; Verhaak RG; Wu CJ; Hammerman PS; Cherniack AD; Getz G; ; Artyomov MN; Schreiber R; Govindan R; Meyerson M
Nat Genet; 2016 Jun; 48(6):607-16. PubMed ID: 27158780
[TBL] [Abstract][Full Text] [Related]
2. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
[TBL] [Abstract][Full Text] [Related]
3. miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.
Del Vescovo V; Cantaloni C; Cucino A; Girlando S; Silvestri M; Bragantini E; Fasanella S; Cuorvo LV; Palma PD; Rossi G; Papotti M; Pelosi G; Graziano P; Cavazza A; Denti MA; Barbareschi M
Am J Surg Pathol; 2011 Feb; 35(2):268-75. PubMed ID: 21263248
[TBL] [Abstract][Full Text] [Related]
4. Decreased sphingomyelin (t34:1) is a candidate predictor for lung squamous cell carcinoma recurrence after radical surgery: a case-control study.
Takanashi Y; Funai K; Eto F; Mizuno K; Kawase A; Tao H; Kitamoto T; Takahashi Y; Sugimura H; Setou M; Kahyo T; Shiiya N
BMC Cancer; 2021 Nov; 21(1):1232. PubMed ID: 34789180
[TBL] [Abstract][Full Text] [Related]
5. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
[TBL] [Abstract][Full Text] [Related]
6. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
Lee HW; Seol HJ; Choi YL; Ju HJ; Joo KM; Ko YH; Lee JI; Nam DH
Int J Oncol; 2012 Dec; 41(6):2013-20. PubMed ID: 23076643
[TBL] [Abstract][Full Text] [Related]
7. New developments in the treatment of squamous cell lung cancer.
Filipits M
Curr Opin Oncol; 2014 Mar; 26(2):152-8. PubMed ID: 24441504
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
[TBL] [Abstract][Full Text] [Related]
9. Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.
Lockwood WW; Wilson IM; Coe BP; Chari R; Pikor LA; Thu KL; Solis LM; Nunez MI; Behrens C; Yee J; English J; Murray N; Tsao MS; Minna JD; Gazdar AF; Wistuba II; MacAulay CE; Lam S; Lam WL
PLoS One; 2012; 7(5):e37775. PubMed ID: 22629454
[TBL] [Abstract][Full Text] [Related]
10. NMR metabolomics of human lung tumours reveals distinct metabolic signatures for adenocarcinoma and squamous cell carcinoma.
Rocha CM; Barros AS; Goodfellow BJ; Carreira IM; Gomes A; Sousa V; Bernardo J; Carvalho L; Gil AM; Duarte IF
Carcinogenesis; 2015 Jan; 36(1):68-75. PubMed ID: 25368033
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941
[TBL] [Abstract][Full Text] [Related]
12. Genomic landscape of squamous cell carcinoma of the lung.
Morgensztern D; Devarakonda S; Govindan R
Am Soc Clin Oncol Educ Book; 2013; ():348-53. PubMed ID: 23714544
[TBL] [Abstract][Full Text] [Related]
13. The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies.
Ho HL; Kao HL; Yeh YC; Chou TY
Diagn Pathol; 2019 Jun; 14(1):59. PubMed ID: 31221183
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical profiling of ALK fusion gene-positive adenocarcinomas of the lung.
Sakai Y; Nakai T; Ohbayashi C; Imagawa N; Yanagita E; Satake R; Nitta A; Kajimoto K; Sakuma T; Itoh T
Int J Surg Pathol; 2013 Oct; 21(5):476-82. PubMed ID: 23794492
[TBL] [Abstract][Full Text] [Related]
15. Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.
Yang S; Chen L; Chan DW; Li QK; Zhang H
Clin Proteomics; 2017; 14():31. PubMed ID: 28814946
[TBL] [Abstract][Full Text] [Related]
16. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
[TBL] [Abstract][Full Text] [Related]
17. Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.
Wang Z; Shen Z; Li Z; Duan J; Fu S; Liu Z; Bai H; Zhang Z; Zhao J; Wang X; Wang J
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9990-5. PubMed ID: 26216950
[TBL] [Abstract][Full Text] [Related]
18. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer?
Vincenten JP; Smit EF; Grünberg K; Postmus PE; Snijders PJ; Witte BI; Heideman DA; Thunnissen E
Lung Cancer; 2015 Jul; 89(1):19-26. PubMed ID: 25982011
[TBL] [Abstract][Full Text] [Related]
19. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
[TBL] [Abstract][Full Text] [Related]
20. Nuclear and mitochondrial DNAs microsatellite instability and mitochondrial DNA copy number in adenocarcinoma and squamous cell carcinoma of lung: a pilot study.
Lee DH; Lee JH; Kim DK; Keum DY
APMIS; 2015 Dec; 123(12):1048-54. PubMed ID: 26547371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
